12 Health Care Stocks Moving In Friday's Pre-Market Session

Loading...
Loading...

 

Gainers

  • Finch Therapeutics Group FNCH stock increased by 55.7% to $3.27 during Friday's pre-market session. The company's market cap stands at $155.5 million.
  • Zymeworks ZYME stock rose 47.78% to $7.33. The company's market cap stands at $423.2 million.
  • Summit Therapeutics SMMT stock moved upwards by 40.36% to $2.33. The company's market cap stands at $228.6 million.
  • NuCana NCNA stock moved upwards by 9.45% to $0.81. The company's market cap stands at $42.2 million. As per the press release, Q4 earnings came out 2 days ago.
  • 4d pharma LBPS stock increased by 9.06% to $3.85. The company's market cap stands at $86.7 million.
  • Aquestive Therapeutics AQST shares rose 8.63% to $1.51. The market value of their outstanding shares is at $62.5 million.

Losers

  • Genocea Biosciences GNCA shares declined by 43.4% to $0.23 during Friday's pre-market session. The market value of their outstanding shares is at $13.5 million.
  • Accolade ACCD shares fell 41.51% to $6.47. The market value of their outstanding shares is at $433.2 million. As per the news, the Q4 earnings report came out yesterday.
  • Statera BioPharma STAB stock fell 15.82% to $0.32. The market value of their outstanding shares is at $16.0 million.
  • Aldeyra Therapeutics ALDX stock fell 12.06% to $3.21. The company's market cap stands at $187.1 million.
  • Evoke Pharma EVOK shares declined by 11.63% to $0.44. The company's market cap stands at $14.4 million.
  • Aclarion ACON stock declined by 7.84% to $2.0. The market value of their outstanding shares is at $15.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Pre-Market OutlookMarketsMoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...